nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—muscle cancer	0.432	0.499	CbGbCtD
Furosemide—PGD—Methotrexate—muscle cancer	0.14	0.161	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—muscle cancer	0.079	0.0911	CbGbCtD
Furosemide—SLC22A11—Methotrexate—muscle cancer	0.0414	0.0478	CbGbCtD
Furosemide—ABCC2—Vincristine—muscle cancer	0.0379	0.0437	CbGbCtD
Furosemide—ABCC2—Etoposide—muscle cancer	0.0347	0.04	CbGbCtD
Furosemide—SLC22A8—Methotrexate—muscle cancer	0.0241	0.0278	CbGbCtD
Furosemide—ABCC2—Doxorubicin—muscle cancer	0.0237	0.0273	CbGbCtD
Furosemide—ABCC2—Methotrexate—muscle cancer	0.0229	0.0265	CbGbCtD
Furosemide—SLC22A6—Methotrexate—muscle cancer	0.0168	0.0194	CbGbCtD
Furosemide—ALB—Methotrexate—muscle cancer	0.0143	0.0165	CbGbCtD
Furosemide—SLC12A1—appendage—muscle cancer	0.00525	0.101	CbGeAlD
Furosemide—CA7—renal system—muscle cancer	0.00176	0.034	CbGeAlD
Furosemide—SLC22A11—renal system—muscle cancer	0.00136	0.0262	CbGeAlD
Furosemide—SLC12A1—renal system—muscle cancer	0.00132	0.0254	CbGeAlD
Furosemide—CA14—cardiac atrium—muscle cancer	0.00132	0.0254	CbGeAlD
Furosemide—SLCO2A1—renal system—muscle cancer	0.00122	0.0235	CbGeAlD
Furosemide—CA9—tendon—muscle cancer	0.00121	0.0233	CbGeAlD
Furosemide—CA14—tendon—muscle cancer	0.00115	0.0221	CbGeAlD
Furosemide—CA12—renal system—muscle cancer	0.00115	0.0221	CbGeAlD
Furosemide—CA6—head—muscle cancer	0.00114	0.022	CbGeAlD
Furosemide—PGD—smooth muscle tissue—muscle cancer	0.00113	0.0217	CbGeAlD
Furosemide—SLCO2A1—cardiac atrium—muscle cancer	0.00109	0.021	CbGeAlD
Furosemide—PGD—renal system—muscle cancer	0.00109	0.0209	CbGeAlD
Furosemide—CA9—testis—muscle cancer	0.001	0.0193	CbGeAlD
Furosemide—PGD—cardiac atrium—muscle cancer	0.000972	0.0187	CbGeAlD
Furosemide—SLCO2A1—tendon—muscle cancer	0.00095	0.0183	CbGeAlD
Furosemide—CA5B—cardiac atrium—muscle cancer	0.000921	0.0177	CbGeAlD
Furosemide—Bumetanide—PTGS2—muscle cancer	0.000909	1	CrCbGaD
Furosemide—CA1—renal system—muscle cancer	0.000908	0.0175	CbGeAlD
Furosemide—SLC12A1—head—muscle cancer	0.000883	0.017	CbGeAlD
Furosemide—SLCO2A1—vagina—muscle cancer	0.000882	0.017	CbGeAlD
Furosemide—SLC12A1—testis—muscle cancer	0.000853	0.0164	CbGeAlD
Furosemide—PGD—tendon—muscle cancer	0.000847	0.0163	CbGeAlD
Furosemide—PGD—bone marrow—muscle cancer	0.00082	0.0158	CbGeAlD
Furosemide—SLCO2A1—head—muscle cancer	0.000815	0.0157	CbGeAlD
Furosemide—CA5B—tendon—muscle cancer	0.000802	0.0155	CbGeAlD
Furosemide—SLCO2A1—testis—muscle cancer	0.000787	0.0152	CbGeAlD
Furosemide—PGD—vagina—muscle cancer	0.000786	0.0151	CbGeAlD
Furosemide—CA2—embryo—muscle cancer	0.000777	0.015	CbGeAlD
Furosemide—CA12—head—muscle cancer	0.000767	0.0148	CbGeAlD
Furosemide—SLC22A8—renal system—muscle cancer	0.000766	0.0148	CbGeAlD
Furosemide—ABCC2—renal system—muscle cancer	0.000747	0.0144	CbGeAlD
Furosemide—CA5B—vagina—muscle cancer	0.000744	0.0143	CbGeAlD
Furosemide—PGD—head—muscle cancer	0.000726	0.014	CbGeAlD
Furosemide—CA4—renal system—muscle cancer	0.000709	0.0137	CbGeAlD
Furosemide—PGD—testis—muscle cancer	0.000701	0.0135	CbGeAlD
Furosemide—CA5B—head—muscle cancer	0.000688	0.0133	CbGeAlD
Furosemide—CA1—bone marrow—muscle cancer	0.000686	0.0132	CbGeAlD
Furosemide—CA5B—testis—muscle cancer	0.000664	0.0128	CbGeAlD
Furosemide—CA4—cardiac atrium—muscle cancer	0.000635	0.0122	CbGeAlD
Furosemide—CA2—smooth muscle tissue—muscle cancer	0.000611	0.0118	CbGeAlD
Furosemide—CA1—head—muscle cancer	0.000607	0.0117	CbGeAlD
Furosemide—CA2—renal system—muscle cancer	0.000588	0.0113	CbGeAlD
Furosemide—ABCC2—tendon—muscle cancer	0.000583	0.0112	CbGeAlD
Furosemide—SLC22A5—renal system—muscle cancer	0.000579	0.0112	CbGeAlD
Furosemide—CA4—tendon—muscle cancer	0.000554	0.0107	CbGeAlD
Furosemide—CA4—bone marrow—muscle cancer	0.000536	0.0103	CbGeAlD
Furosemide—CA2—cardiac atrium—muscle cancer	0.000527	0.0102	CbGeAlD
Furosemide—SLC22A5—cardiac atrium—muscle cancer	0.000518	0.00999	CbGeAlD
Furosemide—ALB—testis—muscle cancer	0.000515	0.00993	CbGeAlD
Furosemide—SLC22A8—head—muscle cancer	0.000512	0.00987	CbGeAlD
Furosemide—ABCC2—testis—muscle cancer	0.000483	0.0093	CbGeAlD
Furosemide—CA4—head—muscle cancer	0.000475	0.00915	CbGeAlD
Furosemide—CA2—tendon—muscle cancer	0.000459	0.00885	CbGeAlD
Furosemide—CA4—testis—muscle cancer	0.000459	0.00884	CbGeAlD
Furosemide—SLC22A5—tendon—muscle cancer	0.000452	0.00871	CbGeAlD
Furosemide—CA2—bone marrow—muscle cancer	0.000445	0.00857	CbGeAlD
Furosemide—CA2—vagina—muscle cancer	0.000426	0.00821	CbGeAlD
Furosemide—SLC22A5—vagina—muscle cancer	0.000419	0.00808	CbGeAlD
Furosemide—Vasculitis—Methotrexate—muscle cancer	0.000399	0.00495	CcSEcCtD
Furosemide—Urinary tract disorder—Vincristine—muscle cancer	0.000398	0.00494	CcSEcCtD
Furosemide—Blood uric acid increased—Methotrexate—muscle cancer	0.000396	0.00492	CcSEcCtD
Furosemide—Urethral disorder—Vincristine—muscle cancer	0.000395	0.0049	CcSEcCtD
Furosemide—CA2—head—muscle cancer	0.000394	0.00758	CbGeAlD
Furosemide—Erythema—Dactinomycin—muscle cancer	0.000392	0.00487	CcSEcCtD
Furosemide—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000383	0.00476	CcSEcCtD
Furosemide—CA2—testis—muscle cancer	0.00038	0.00733	CbGeAlD
Furosemide—SLC22A5—testis—muscle cancer	0.000374	0.00721	CbGeAlD
Furosemide—Hypocalcaemia—Doxorubicin—muscle cancer	0.000368	0.00457	CcSEcCtD
Furosemide—Angiopathy—Vincristine—muscle cancer	0.000365	0.00454	CcSEcCtD
Furosemide—Aplastic anaemia—Methotrexate—muscle cancer	0.000365	0.00453	CcSEcCtD
Furosemide—Hyperuricaemia—Doxorubicin—muscle cancer	0.000363	0.00451	CcSEcCtD
Furosemide—Anaemia—Dactinomycin—muscle cancer	0.000363	0.0045	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00036	0.00447	CcSEcCtD
Furosemide—Renal failure—Etoposide—muscle cancer	0.000357	0.00443	CcSEcCtD
Furosemide—Urine output increased—Methotrexate—muscle cancer	0.000352	0.00437	CcSEcCtD
Furosemide—Bladder pain—Methotrexate—muscle cancer	0.000352	0.00437	CcSEcCtD
Furosemide—Leukopenia—Dactinomycin—muscle cancer	0.000351	0.00436	CcSEcCtD
Furosemide—Hepatobiliary disease—Etoposide—muscle cancer	0.000344	0.00427	CcSEcCtD
Furosemide—Blood uric acid increased—Doxorubicin—muscle cancer	0.000343	0.00426	CcSEcCtD
Furosemide—Agranulocytosis—Etoposide—muscle cancer	0.000339	0.00421	CcSEcCtD
Furosemide—Thrombophlebitis—Methotrexate—muscle cancer	0.000326	0.00405	CcSEcCtD
Furosemide—Diabetes mellitus—Methotrexate—muscle cancer	0.000325	0.00403	CcSEcCtD
Furosemide—Anaemia—Vincristine—muscle cancer	0.000324	0.00402	CcSEcCtD
Furosemide—Urinary tract disorder—Etoposide—muscle cancer	0.000322	0.004	CcSEcCtD
Furosemide—Agitation—Vincristine—muscle cancer	0.000322	0.004	CcSEcCtD
Furosemide—Photosensitivity—Methotrexate—muscle cancer	0.000322	0.00399	CcSEcCtD
Furosemide—Polyuria—Methotrexate—muscle cancer	0.000322	0.00399	CcSEcCtD
Furosemide—Urethral disorder—Etoposide—muscle cancer	0.00032	0.00397	CcSEcCtD
Furosemide—Aplastic anaemia—Doxorubicin—muscle cancer	0.000316	0.00393	CcSEcCtD
Furosemide—Vertigo—Vincristine—muscle cancer	0.000315	0.00391	CcSEcCtD
Furosemide—Leukopenia—Vincristine—muscle cancer	0.000314	0.0039	CcSEcCtD
Furosemide—Thrombocytopenia—Dactinomycin—muscle cancer	0.000314	0.00389	CcSEcCtD
Furosemide—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00031	0.00384	CcSEcCtD
Furosemide—Erythema multiforme—Etoposide—muscle cancer	0.000308	0.00383	CcSEcCtD
Furosemide—Anorexia—Dactinomycin—muscle cancer	0.000305	0.00379	CcSEcCtD
Furosemide—Eye disorder—Etoposide—muscle cancer	0.000305	0.00378	CcSEcCtD
Furosemide—Bladder pain—Doxorubicin—muscle cancer	0.000305	0.00378	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000299	0.00372	CcSEcCtD
Furosemide—Angiopathy—Etoposide—muscle cancer	0.000296	0.00367	CcSEcCtD
Furosemide—Immune system disorder—Etoposide—muscle cancer	0.000295	0.00366	CcSEcCtD
Furosemide—Mental disability—Doxorubicin—muscle cancer	0.000292	0.00363	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000292	0.00362	CcSEcCtD
Furosemide—Lethargy—Methotrexate—muscle cancer	0.000288	0.00358	CcSEcCtD
Furosemide—Anaphylactic shock—Vincristine—muscle cancer	0.000286	0.00355	CcSEcCtD
Furosemide—Thrombophlebitis—Doxorubicin—muscle cancer	0.000283	0.00351	CcSEcCtD
Furosemide—Diabetes mellitus—Doxorubicin—muscle cancer	0.000281	0.00349	CcSEcCtD
Furosemide—Nervous system disorder—Vincristine—muscle cancer	0.000281	0.00348	CcSEcCtD
Furosemide—Thrombocytopenia—Vincristine—muscle cancer	0.00028	0.00348	CcSEcCtD
Furosemide—Photosensitivity—Doxorubicin—muscle cancer	0.000279	0.00346	CcSEcCtD
Furosemide—Decreased appetite—Dactinomycin—muscle cancer	0.000278	0.00346	CcSEcCtD
Furosemide—Dysgeusia—Etoposide—muscle cancer	0.000278	0.00345	CcSEcCtD
Furosemide—Hyperhidrosis—Vincristine—muscle cancer	0.000277	0.00343	CcSEcCtD
Furosemide—Fatigue—Dactinomycin—muscle cancer	0.000276	0.00343	CcSEcCtD
Furosemide—Pain—Dactinomycin—muscle cancer	0.000274	0.0034	CcSEcCtD
Furosemide—Vascular purpura—Doxorubicin—muscle cancer	0.000273	0.00339	CcSEcCtD
Furosemide—Muscle spasms—Etoposide—muscle cancer	0.000273	0.00339	CcSEcCtD
Furosemide—Anorexia—Vincristine—muscle cancer	0.000273	0.00339	CcSEcCtD
Furosemide—Irritability—Methotrexate—muscle cancer	0.00027	0.00335	CcSEcCtD
Furosemide—Hypotension—Vincristine—muscle cancer	0.000267	0.00332	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—muscle cancer	0.000264	0.00328	CcSEcCtD
Furosemide—Anaemia—Etoposide—muscle cancer	0.000262	0.00326	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000262	0.00325	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000259	0.00322	CcSEcCtD
Furosemide—Paraesthesia—Vincristine—muscle cancer	0.000257	0.00319	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—muscle cancer	0.000256	0.00318	CcSEcCtD
Furosemide—Vertigo—Etoposide—muscle cancer	0.000255	0.00317	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000254	0.00316	CcSEcCtD
Furosemide—Leukopenia—Etoposide—muscle cancer	0.000254	0.00316	CcSEcCtD
Furosemide—Purpura—Doxorubicin—muscle cancer	0.000254	0.00315	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—muscle cancer	0.000253	0.00314	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—muscle cancer	0.000253	0.00314	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000253	0.00314	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—muscle cancer	0.00025	0.0031	CcSEcCtD
Furosemide—Decreased appetite—Vincristine—muscle cancer	0.000249	0.00309	CcSEcCtD
Furosemide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000247	0.00307	CcSEcCtD
Furosemide—Fatigue—Vincristine—muscle cancer	0.000247	0.00306	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—muscle cancer	0.000246	0.00305	CcSEcCtD
Furosemide—Pain—Vincristine—muscle cancer	0.000245	0.00304	CcSEcCtD
Furosemide—Constipation—Vincristine—muscle cancer	0.000245	0.00304	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—muscle cancer	0.000242	0.003	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00024	0.00298	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—muscle cancer	0.000239	0.00297	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—muscle cancer	0.000236	0.00293	CcSEcCtD
Furosemide—Gastrointestinal pain—Vincristine—muscle cancer	0.000234	0.0029	CcSEcCtD
Furosemide—Confusional state—Etoposide—muscle cancer	0.000234	0.0029	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—muscle cancer	0.000232	0.00288	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—muscle cancer	0.00023	0.00285	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—muscle cancer	0.000229	0.00284	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—muscle cancer	0.000227	0.00282	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—muscle cancer	0.000227	0.00282	CcSEcCtD
Furosemide—Abdominal pain—Vincristine—muscle cancer	0.000226	0.00281	CcSEcCtD
Furosemide—Body temperature increased—Vincristine—muscle cancer	0.000226	0.00281	CcSEcCtD
Furosemide—Skin disorder—Etoposide—muscle cancer	0.000225	0.00279	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—muscle cancer	0.000224	0.00278	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000223	0.00277	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—muscle cancer	0.000223	0.00277	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—muscle cancer	0.000223	0.00276	CcSEcCtD
Furosemide—Anorexia—Etoposide—muscle cancer	0.000221	0.00274	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00022	0.00273	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—muscle cancer	0.000219	0.00272	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—muscle cancer	0.000218	0.0027	CcSEcCtD
Furosemide—Hypotension—Etoposide—muscle cancer	0.000217	0.00269	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000216	0.00268	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—muscle cancer	0.000216	0.00268	CcSEcCtD
Furosemide—Renal failure—Methotrexate—muscle cancer	0.000214	0.00266	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—muscle cancer	0.000213	0.00264	CcSEcCtD
Furosemide—Hypersensitivity—Vincristine—muscle cancer	0.000211	0.00262	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—muscle cancer	0.000209	0.0026	CcSEcCtD
Furosemide—Sweating—Methotrexate—muscle cancer	0.000209	0.00259	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—muscle cancer	0.000208	0.00258	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—muscle cancer	0.000207	0.00257	CcSEcCtD
Furosemide—Somnolence—Etoposide—muscle cancer	0.000206	0.00256	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—muscle cancer	0.000206	0.00256	CcSEcCtD
Furosemide—Asthenia—Vincristine—muscle cancer	0.000205	0.00255	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—muscle cancer	0.000204	0.00253	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—muscle cancer	0.000203	0.00252	CcSEcCtD
Furosemide—Rash—Dactinomycin—muscle cancer	0.000202	0.00251	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—muscle cancer	0.000201	0.0025	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—muscle cancer	0.0002	0.00248	CcSEcCtD
Furosemide—Fatigue—Etoposide—muscle cancer	0.0002	0.00248	CcSEcCtD
Furosemide—Pain—Etoposide—muscle cancer	0.000198	0.00246	CcSEcCtD
Furosemide—Constipation—Etoposide—muscle cancer	0.000198	0.00246	CcSEcCtD
Furosemide—Diarrhoea—Vincristine—muscle cancer	0.000196	0.00243	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—muscle cancer	0.000195	0.00242	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—muscle cancer	0.000193	0.0024	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000193	0.0024	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—muscle cancer	0.000192	0.00238	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—muscle cancer	0.000191	0.00237	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—muscle cancer	0.000191	0.00237	CcSEcCtD
Furosemide—Nausea—Dactinomycin—muscle cancer	0.00019	0.00236	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—muscle cancer	0.00019	0.00235	CcSEcCtD
Furosemide—Dizziness—Vincristine—muscle cancer	0.000189	0.00235	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—muscle cancer	0.000188	0.00234	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—muscle cancer	0.000188	0.00234	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000187	0.00232	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—muscle cancer	0.000185	0.0023	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—muscle cancer	0.000185	0.00229	CcSEcCtD
Furosemide—Urticaria—Etoposide—muscle cancer	0.000184	0.00229	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—muscle cancer	0.000183	0.00227	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—muscle cancer	0.000183	0.00227	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—muscle cancer	0.000183	0.00227	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—muscle cancer	0.000182	0.00226	CcSEcCtD
Furosemide—Vomiting—Vincristine—muscle cancer	0.000182	0.00226	CcSEcCtD
Furosemide—Sweating—Doxorubicin—muscle cancer	0.000181	0.00224	CcSEcCtD
Furosemide—Rash—Vincristine—muscle cancer	0.00018	0.00224	CcSEcCtD
Furosemide—Dermatitis—Vincristine—muscle cancer	0.00018	0.00224	CcSEcCtD
Furosemide—Headache—Vincristine—muscle cancer	0.000179	0.00222	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000178	0.00221	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—muscle cancer	0.000177	0.0022	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—muscle cancer	0.000177	0.00219	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—muscle cancer	0.000176	0.00218	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—muscle cancer	0.000171	0.00212	CcSEcCtD
Furosemide—Erythema—Methotrexate—muscle cancer	0.00017	0.00211	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—muscle cancer	0.00017	0.00211	CcSEcCtD
Furosemide—Nausea—Vincristine—muscle cancer	0.00017	0.00211	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000167	0.00207	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—muscle cancer	0.000167	0.00207	CcSEcCtD
Furosemide—Asthenia—Etoposide—muscle cancer	0.000166	0.00206	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—muscle cancer	0.000166	0.00206	CcSEcCtD
Furosemide—Pruritus—Etoposide—muscle cancer	0.000164	0.00204	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—muscle cancer	0.000163	0.00202	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—muscle cancer	0.00016	0.00199	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—muscle cancer	0.00016	0.00199	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—muscle cancer	0.000159	0.00197	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—muscle cancer	0.000158	0.00196	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—muscle cancer	0.000158	0.00196	CcSEcCtD
Furosemide—Anaemia—Methotrexate—muscle cancer	0.000157	0.00195	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—muscle cancer	0.000154	0.00191	CcSEcCtD
Furosemide—Dizziness—Etoposide—muscle cancer	0.000153	0.0019	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—muscle cancer	0.000153	0.0019	CcSEcCtD
Furosemide—Vertigo—Methotrexate—muscle cancer	0.000153	0.0019	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—muscle cancer	0.000152	0.00189	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—muscle cancer	0.000151	0.00188	CcSEcCtD
Furosemide—Vomiting—Etoposide—muscle cancer	0.000147	0.00183	CcSEcCtD
Furosemide—Erythema—Doxorubicin—muscle cancer	0.000147	0.00183	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—muscle cancer	0.000147	0.00183	CcSEcCtD
Furosemide—Rash—Etoposide—muscle cancer	0.000146	0.00181	CcSEcCtD
Furosemide—Dermatitis—Etoposide—muscle cancer	0.000146	0.00181	CcSEcCtD
Furosemide—Headache—Etoposide—muscle cancer	0.000145	0.0018	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—muscle cancer	0.000145	0.0018	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—muscle cancer	0.000144	0.00179	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000144	0.00179	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—muscle cancer	0.000142	0.00176	CcSEcCtD
Furosemide—Confusional state—Methotrexate—muscle cancer	0.00014	0.00174	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—muscle cancer	0.000139	0.00172	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—muscle cancer	0.000139	0.00172	CcSEcCtD
Furosemide—Nausea—Etoposide—muscle cancer	0.000138	0.00171	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—muscle cancer	0.000136	0.00169	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—muscle cancer	0.000136	0.00169	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—muscle cancer	0.000136	0.00169	CcSEcCtD
Furosemide—Agitation—Doxorubicin—muscle cancer	0.000135	0.00168	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—muscle cancer	0.000135	0.00167	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—muscle cancer	0.000134	0.00167	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—muscle cancer	0.000132	0.00164	CcSEcCtD
Furosemide—Anorexia—Methotrexate—muscle cancer	0.000132	0.00164	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—muscle cancer	0.000132	0.00164	CcSEcCtD
Furosemide—Hypotension—Methotrexate—muscle cancer	0.00013	0.00161	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—muscle cancer	0.000125	0.00155	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000125	0.00155	CcSEcCtD
Furosemide—Somnolence—Methotrexate—muscle cancer	0.000123	0.00153	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—muscle cancer	0.000123	0.00152	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—muscle cancer	0.000121	0.0015	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—muscle cancer	0.000121	0.0015	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00012	0.00149	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00012	0.00149	CcSEcCtD
Furosemide—Fatigue—Methotrexate—muscle cancer	0.00012	0.00149	CcSEcCtD
Furosemide—Pain—Methotrexate—muscle cancer	0.000119	0.00147	CcSEcCtD
Furosemide—Shock—Doxorubicin—muscle cancer	0.000118	0.00147	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—muscle cancer	0.000118	0.00146	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000118	0.00146	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—muscle cancer	0.000117	0.00145	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000116	0.00144	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—muscle cancer	0.000115	0.00142	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—muscle cancer	0.000114	0.00142	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000114	0.00141	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—muscle cancer	0.000112	0.00139	CcSEcCtD
Furosemide—Urticaria—Methotrexate—muscle cancer	0.00011	0.00137	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—muscle cancer	0.00011	0.00136	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—muscle cancer	0.00011	0.00136	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—muscle cancer	0.000108	0.00134	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—muscle cancer	0.000107	0.00133	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—muscle cancer	0.000105	0.0013	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000104	0.00129	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—muscle cancer	0.000104	0.00129	CcSEcCtD
Furosemide—Pain—Doxorubicin—muscle cancer	0.000103	0.00128	CcSEcCtD
Furosemide—Constipation—Doxorubicin—muscle cancer	0.000103	0.00128	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—muscle cancer	0.000102	0.00127	CcSEcCtD
Furosemide—Asthenia—Methotrexate—muscle cancer	9.96e-05	0.00124	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—muscle cancer	9.91e-05	0.00123	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—muscle cancer	9.83e-05	0.00122	CcSEcCtD
Furosemide—Pruritus—Methotrexate—muscle cancer	9.82e-05	0.00122	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—muscle cancer	9.55e-05	0.00119	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—muscle cancer	9.5e-05	0.00118	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—muscle cancer	9.5e-05	0.00118	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—muscle cancer	9.5e-05	0.00118	CcSEcCtD
Furosemide—Dizziness—Methotrexate—muscle cancer	9.18e-05	0.00114	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—muscle cancer	8.86e-05	0.0011	CcSEcCtD
Furosemide—Vomiting—Methotrexate—muscle cancer	8.83e-05	0.0011	CcSEcCtD
Furosemide—Rash—Methotrexate—muscle cancer	8.75e-05	0.00109	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—muscle cancer	8.75e-05	0.00109	CcSEcCtD
Furosemide—Headache—Methotrexate—muscle cancer	8.7e-05	0.00108	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—muscle cancer	8.63e-05	0.00107	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—muscle cancer	8.51e-05	0.00106	CcSEcCtD
Furosemide—Nausea—Methotrexate—muscle cancer	8.25e-05	0.00102	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—muscle cancer	8.23e-05	0.00102	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—muscle cancer	7.95e-05	0.000987	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—muscle cancer	7.64e-05	0.000949	CcSEcCtD
Furosemide—Rash—Doxorubicin—muscle cancer	7.58e-05	0.000941	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—muscle cancer	7.57e-05	0.00094	CcSEcCtD
Furosemide—Headache—Doxorubicin—muscle cancer	7.53e-05	0.000935	CcSEcCtD
Furosemide—Nausea—Doxorubicin—muscle cancer	7.14e-05	0.000886	CcSEcCtD
